Research Paper Volume 15, Issue 21 pp 12314—12329
Cuproptosis-related gene DLAT serves as a prognostic biomarker for immunotherapy in clear cell renal cell carcinoma: multi-database and experimental verification
Figure 1. Pan-cancer analysis and expression level verification of DLAT in ccRCC. (A) Expression levels of DLAT in multiple tumors. Yellow background color indicates the expression of DLAT in KIRC. (B) Comparison of paired DLAT expression levels in ccRCC from TCGA. (C) Comparison of paired DLAT expression levels in ccRCC from ICGC (RECA-EU). (D) Comparison of paired DLAT expression levels in ccRCC from GEO (GSE36895). (E) Comparison of paired DLAT expression levels in ccRCC from NBUNH data cohort. *: P< 0.05; **: P< 0.01; ***: P< 0.001.